National symposium presentation to focus on heparin-induced thrombocytopenia
On Dec. 4, Mayo Clinic Laboratories will host the Friday Satellite Symposium A Case-Based Workshop: Clinical and Laboratory Aspects of Hemophilia and Thrombosis, preceding the 62nd American Society of Hematology Annual Meeting and Exposition.
During the symposium, Anand Padmanabhan, M.B.B.S., Ph.D., will present "Advances in the Diagnosis of Heparin-Induced Thrombocytopenia."
"Diagnosis of heparin-induced thrombocytopenia can be challenging, "Dr. Padmanabhan says. "The risks associated with delayed diagnosis and misdiagnosis can be high."
Dr. Padmanabhan's presentation will provide an overview of heparin-induced thrombocytopenia (HIT) diagnostic testing, focusing on functional HIT testing. He also will discuss a recently concluded prospective, blinded study on the use of PF4-treated platelets for HIT diagnosis. In addition, the presentation will offer a discussion of new ways to detect HIT antibodies and further advances that can be made to facilitate timely and accurate diagnosis.
A physician-scientist and consultant in the divisions of Hematopathology, Transfusion Medicine and Experimental Pathology at Mayo Clinic, Dr. Padmanabhan conducts NIH-funded research focused on pathophysiology, diagnosis, and treatment of heparin-induced thrombocytopenia. He also has clinical interests in the evidenced-based use of apheresis in human disease.
The symposium agenda, information about continuing education credits, and registration details are available on the event website. Registration is limited to 300 attendees. The deadline to register is Thursday, Dec. 3, at 5 p.m. CT.